By Joshua Burd
French biopharmaceutical firm Ipsen is moving its U.S headquarters out of New Jersey and into Massachusetts, although it said it still plans to maintain a presence in the Garden State.
The company said last week that it would establish a new North American headquarters in Cambridge, the biotech and higher education hub just outside Boston, by consolidating its U.S. operations. That includes Ipsen’s current headquarters office in the Basking Ridge section of Bernards, its home since 2012 after it relocated from Brisbane, California.
At the time, the company signed a six-and-a-half-year lease for 30,000 square feet at 106 Allen Road. Executives said Thursday that the headquarters will transition to Cambridge over the next 12 months, but the company will “maintain a core services center” in Basking Ridge.
“We are entering into a new era of innovation and growth for Ipsen as a leading global biotech company,” said Richard Paulson, CEO of Ipsen North America. “By bringing our headquarters to Cambridge, we will build a sustainable innovation engine to advance opportunities for our employees and our overall business.”
Ipsen made the announcement at last week’s 2018 BIO International Convention in Boston alongside the Massachusetts Life Sciences Center, an economic development investment agency. As a result of the move, the company will co-locate its North America units with several other divisions to create a fully integrated biopharmaceutical business in one place.
The company also said it will capitalize on Cambridge’s biotech ecosystem to support its accelerated growth, raise its profile and visibility as an employer and partner of choice.
